Literature DB >> 7847349

Acute renal failure associated with immunoglobulin therapy.

T G Cantú1, E W Hoehn-Saric, K M Burgess, L Racusen, P J Scheel.   

Abstract

Four cases of acute renal failure induced by intravenous immunoglobulin are presented, and the literature on the subject is reviewed. The clinical course varies from asymptomatic serum creatinine elevation to anuric renal failure occurring within days of the institution of therapy, followed by the rapid recovery of renal function after termination of therapy. The renal histology demonstrates severe tubular vacuolization with cellular swelling and preservation of the brush border. Glomerular endothelial, mesangial, and epithelial cells also may demonstrate swelling and vacuolization. There is no evidence for inflammatory or immune complex-mediated etiologies. The immunoglobulins or carbohydrate additives in the preparations appear to have a unique and reversible effect on the glomerular and tubular cell function.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7847349     DOI: 10.1016/0272-6386(95)90003-9

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  13 in total

Review 1.  Adverse effects of intravenous immunoglobulin therapy.

Authors:  U E Nydegger; M Sturzenegger
Journal:  Drug Saf       Date:  1999-09       Impact factor: 5.606

Review 2.  Recognition and management of systemic lupus erythematosus.

Authors:  J O Schroeder; H H Euler
Journal:  Drugs       Date:  1997-09       Impact factor: 9.546

Review 3.  [Intravenous immunoglobulins in chronic idiopathic myositis].

Authors:  H Michels; G-R Burmester; F Buttgereit
Journal:  Z Rheumatol       Date:  2005-03       Impact factor: 1.372

Review 4.  Ritonavir-induced acute kidney injury: kidney biopsy findings and review of literature.

Authors:  T Shafi; M J Choi; L C Racusen; L A Spacek; C Berry; M Atta; D M Fine
Journal:  Clin Nephrol       Date:  2011-02       Impact factor: 0.975

Review 5.  Acute kidney injury in the fetus and neonate.

Authors:  Arwa Nada; Elizabeth M Bonachea; David J Askenazi
Journal:  Semin Fetal Neonatal Med       Date:  2016-12-26       Impact factor: 3.926

6.  Intravenous gammaglobulin-induced chronic renal failure in a patient with multiple myeloma.

Authors:  Alper Sevinc; Celalettin Camci; Suleyman Buyukberber; Bulent Akgul
Journal:  Med Oncol       Date:  2007       Impact factor: 3.064

Review 7.  Treatment of lupus nephritis.

Authors:  Fayez F Hejaili; Louise M Moist; William F Clark
Journal:  Drugs       Date:  2003       Impact factor: 9.546

Review 8.  Pure red cell aplasia due to parvovirus B19 infection after liver transplantation: a case report and review of the literature.

Authors:  Ting-Bo Liang; Dong-Lin Li; Jun Yu; Xue-Li Bai; Liang Liang; Shi-Guo Xu; Wei-Lin Wang; Yan Shen; Min Zhang; Shu-Sen Zheng
Journal:  World J Gastroenterol       Date:  2007-04-07       Impact factor: 5.742

9.  True hyponatremia secondary to intravenous immunoglobulin.

Authors:  Minhtri K Nguyen; Anjay Rastogi; Ira Kurtz
Journal:  Clin Exp Nephrol       Date:  2006-06       Impact factor: 2.617

10.  Infusion of Reconstituted High-Density Lipoprotein, CSL112, in Patients With Atherosclerosis: Safety and Pharmacokinetic Results From a Phase 2a Randomized Clinical Trial.

Authors:  Pierluigi Tricoci; Denise M D'Andrea; Paul A Gurbel; Zhenling Yao; Marina Cuchel; Brion Winston; Robert Schott; Robert Weiss; Michael A Blazing; Louis Cannon; Alison Bailey; Dominick J Angiolillo; Andreas Gille; Charles L Shear; Samuel D Wright; John H Alexander
Journal:  J Am Heart Assoc       Date:  2015-08-25       Impact factor: 5.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.